Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin

BACKGROUND: Three-weekly high-dose cisplatin (100 mg/m(2)) is considered the standard systemic regimen given concurrently with postoperative or definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). Concurrent chemoradiation (CRT) with high-dose cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Vorst, Maurice J. D. L., Neefjes, Elisabeth C. W., Toffoli, Elisa C., Oosterling-Jansen, Jolanda E. W., Vergeer, Marije R., Leemans, C. René, Kooistra, Menno P., Voortman, Jens, Verheul, Henk M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839050/
https://www.ncbi.nlm.nih.gov/pubmed/31703649
http://dx.doi.org/10.1186/s12885-019-6233-9

Ejemplares similares

Ejemplares similares